[ad_1] Mortality significantly decreased in patients with Skelleftezjukan who received the drug drug tafamidis. Hospital facilities also declined and patients gained mobility and quality of life. It shows an international study in …
Read More »
[ad_1] – Det är signifikanta skillnader som ger hopp åt många med Skelleftesjukan, säger Kurt Boman, senior professor vid Umeå universitet och kardiolog vid Skellefteå lasarett och en av dem som har …
Read More »
[ad_1] There are drug candidates Patisiran and Inotersen studied. They seem to slow down the production of proteins that causes the symptoms of skeletal disease. Drabbas, a storage of insoluble protein complexes …
Read More »